Agung Putu Surya Purna Kristyawan/iStock via Getty Images
An analysis of insurance claims data found that if GLP-1 medications for weight loss and diabetes are priced below $350, it results in net savings for payors, such as employers and plan sponsors, through reduced use of health care services that result.